An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF.
In the majority of patients with acquired thrombotic thrombocytopenic purpura (TTP), antibodies are directed toward the spacer domain of ADAMTS13. We have previously shown that region Y658-Y665 is involved. We now show that replacement of R660, Y661, or Y665 with alanine in ADAMTS13 reduced/abolished the binding of 2 previously isolated human monoclonal antibodies and polyclonal antibodies derived from plasma of 6 patients with acquired TTP. We investigated whether these residues also influenced cleavage of short von Willebrand factor (VWF) fragment substrate VWF115. An ADAMTS13 variant (R660A/Y661A/Y665A, ADAMTS13-RYY) showed a 12-fold reduced catalytic efficiency (k(cat)/K(m)) arising from greatly reduced (> 25-fold) binding, demonstrated by surface plasmon resonance. The influence of these residue changes on full-length VWF was determined with denaturing and flow assays. ADAMTS13-RYY had reduced activity in both, with proteolysis of VWF unaffected by autoantibody. Binding of ADAMTS13-RYY mutant to VWF was, however, similar to normal. Our results demonstrate that residues within Y658-Y665 of the ADAMTS13 spacer domain that are targeted by autoantibodies in TTP directly interact with a complementary exosite (E1660-R1668) within the VWF A2 domain. Residues R660, Y661, and Y665 are critical for proteolysis of short VWF substrates, but wider domain interactions also make important contributions to cleavage of full-length VWF.
Pos
Wouter
W
Department of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, The Netherlands.
Crawley
James T B
JT
Fijnheer
Rob
R
Voorberg
Jan
J
Lane
David A
DA
Luken
Brenda M
BM
D051722:ADAM Proteins / Q000235:genetics / Q000378:metabolism*; D000071120:ADAMTS13 Protein; D019943:Amino Acid Substitution; D001323:Autoantibodies / Q000235:genetics / Q000378:metabolism*; D001665:Binding Sites; D018604:Epitope Mapping / Q000379:methods; D000939:Epitopes / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D020125:Mutation, Missense; D011485:Protein Binding; D017434:Protein Structure, Tertiary / Q000235:genetics; D011697:Purpura, Thrombotic Thrombocytopenic / Q000235:genetics / Q000378:metabolism*; D020349:Surface Plasmon Resonance; D014841:von Willebrand Factor / Q000235:genetics / Q000378:metabolism*
D001323:Autoantibodies; D000939:Epitopes; D014841:von Willebrand Factor; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human